Search Results - "Wolgast, Nadine"

Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens by Baden, David, Zukunft, Sven, Hernandez, Gema, Wolgast, Nadine, Steinhauser, Sophie, Pohlmann, Alexander, Schliemann, Christoph, Mikesch, Jan-Henrik, Steffen, Bjorn, Sauer, Tim, Hanoun, Maher, Schafer-Eckart, Kerstin, Krause, Stefan W, Hanel, Mathias, Einsele, Hermann, Jost, Edgar, Brummendorf, Tim H, Scholl, Sebastian, Hochhaus, Andreas, Neubauer, Andreas, Burchert, Andreas, Kaufmann, Martin, Niemann, Dirk, Schaich, Markus, Blau, Wolfgang, Kiani, Alexander, Gorner, Martin, Kaiser, Ulrich, Kullmer, Johannes, Weber, Thomas, Berdel, Wolfgang E, Ehninger, Gerhard, Muller-Tidow, Carsten, Platzbecker, Uwe, Serve, Hubert, Bornhauser, Martin, Rollig, Christoph, Baldus, Claudia D, Fransecky, Lars

“…In newly diagnosed acute myeloid leukemia (AML), immediate initiation of treatment is standard of care. However, deferral of antileukemic therapy may be…”
Get full text

The Gene Expression Classifier ALLCatchR Identifies B‐cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age by Beder, Thomas, Hansen, Björn‐Thore, Hartmann, Alina M., Zimmermann, Johannes, Amelunxen, Eric, Wolgast, Nadine, Walter, Wencke, Zaliova, Marketa, Antić, Željko, Chouvarine, Philippe, Bartsch, Lorenz, Barz, Malwine J., Bultmann, Miriam, Horns, Johanna, Bendig, Sonja, Kässens, Jan, Kaleta, Christoph, Cario, Gunnar, Schrappe, Martin, Neumann, Martin, Gökbuget, Nicola, Bergmann, Anke Katharina, Trka, Jan, Haferlach, Claudia, Brüggemann, Monika, Baldus, Claudia D., Bastian, Lorenz

“…Current classifications (World Health Organization‐HAEM5/ICC) define up to 26 molecular B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) disease…”
Get full text

Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL by Bastian, Lorenz, Beder, Thomas, Barz, Malwine J., Bendig, Sonja, Bartsch, Lorenz, Walter, Wencke, Wolgast, Nadine, Brändl, Björn, Rohrandt, Christian, Hansen, Björn-Thore, Hartmann, Alina M., Iben, Katharina, Das Gupta, Dennis, Denker, Miriam, Zimmermann, Johannes, Wittig, Michael, Chitadze, Guranda, Neumann, Martin, Schneller, Folker, Fiedler, Walter, Steffen, Björn, Stelljes, Matthias, Faul, Christoph, Schwartz, Stefan, Müller, Franz-Josef, Cario, Gunnar, Harder, Lana, Haferlach, Claudia, Pfeifer, Heike, Gökbuget, Nicola, Brüggemann, Monika, Baldus, Claudia D.

“…•“Multilineage” vs “lymphoid-only” BCR::ABL1 involvement and distinct cooperating events determine gene expression in BCR::ABL1-positive ALL.•Outcome with…”
Get full text

Molecular Subtypes in BCR::ABL1-Positive ALL Are Defined By Cellular Origins and Cooperating Genomic Events by Bastian, Lorenz, Beder, Thomas, Barz, Malwine, Bendig, Sonja, Bartsch, Lorenz, Walter, Wencke, Wolgast, Nadine, Brändl, Björn, Rohrandt, Christian, Hansen, Björn-Thore, Hartmann, Alina M., Iben, Katharina, Bultmann, Miriam, Zimmermann, Johannes, Wittig, Michael, Chitadze, Guranda, Neumann, Martin, Schneller, Folker, Fiedler, Walter, Steffen, Björn, Stelljes, Matthias, Faul, Christoph, Schwartz, Stefan, Müller, Franz-Josef, Cario, Gunnar, Harder, Lana, Haferlach, Claudia, Pfeifer, Heike, Goekbuget, Nicola, Brüggemann, Monika, Baldus, Claudia D

“…Two developmental trajectories are acknowledged in BCR::ABL1-positive acute lymphoblastic leukemia (ALL) as distinct diagnostic entities by the ICC…”
Get full text

In-Depth Immune Profiling in Children with BCP-ALL within the AIEOP-BFM ALL 2017 Study by Laqua, Anna, Raifer, Hartmann, Kelm, Miriam, Horns, Johanna, Sharma, Arunabh, Möricke, Anja, Vossen-Gajcy, Michaela, Alten, Julia, Fischer-Riepe, Lena, Altvater, Bianca, Rasa, Mahdi, Kehden, Britta, Proske, Constantin, Kässens, Jan, Beder, Thomas, Bendig, Sonja, Wolgast, Nadine, Bastian, Lorenz, Ritgen, Matthias, Huber, Magdalena, Dempfle, Astrid, Baldus, Claudia D, Cario, Gunnar, Schrappe, Martin, Rossig, Claudia, Brüggemann, Monika, Chitadze, Guranda

“…The international multicenter frontline therapy trial AIEOP-BFM ALL 2017 prospectively randomizes CD19-targeting T-cell engager blinatumomab (BLN) against…”
Get full text

Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols by Neumann, Martin, Beder, Thomas, Bastian, Lorenz, Hänzelmann, Sonja, Bultmann, Miriam, Wolgast, Nadine, Hartmann, Alina, Trautmann, Heiko, Ortiz-Tanchez, Jutta, Schlee, Cornelia, Schroeder, Michael, Fransecky, Lars, Vosberg, Sebastian, Fiedler, Walter, Alakel, Nael, Heberling, Lisa, Kondakci, Mustafa, Starck, Michael, Schwartz, Stefan, Raffel, Simon, Müller-Tidow, Carsten, Schneller, Folker, Reichle, Albrecht, Burmeister, Thomas, Greif, Philipp A., Brüggemann, Monika, Gökbuget, Nicola, Baldus, Claudia D.

“…In contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are less well defined in T-lineage ALL. Comprehensive studies on…”
Get full text